AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Bubs Australia Limited
Video analysis: BUBSF
All videosNo video analysis for this stock yet. Request one from our team.
News: BUBSF
Bubs Australia Limited (BUBSF) Discusses FDA Authorization Milestone and US Growth Strategy in Infant Formula Market Transcript
Bubs Australia Limited (BUBSF) Discusses FDA Authorization Milestone and US Growth Strategy in Infant Formula Market Transcript
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump
Bubs Australia said on Monday it secured permanent authorisation from the U.S. Food and Drug Administration to sell three infant formula products in the country, putting the stock on course for its biggest one-day gain since May 2022.
Bubs Australia Limited (BUBSF) Q4 2026 Earnings Call Transcript
Bubs Australia Limited (BUBSF) Q4 2026 Earnings Call Transcript
Similar companies
-
Global Bio-chem Technology Group Company Limited
GBCMY
·
Other OTC
Compare
-
Shenguan Holdings (Group) Limited
SHGXY
·
Other OTC
Compare
-
EC Healthcare
UNHLF
·
Other OTC
Compare
-
Reed's, Inc.
REED
·
New York Stock Exchange Arca
Compare
-
Natural Beauty Bio-Technology Limited
NBBTF
·
Other OTC
Compare
-
Crimson Wine Group, Ltd.
CWGL
·
Other OTC
Compare